MedTrace Logo

Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device

NCT02452671 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2017-03-22

No results posted yet for this study

Summary

This is a multi-center, non-randomized, observational study to further evaluate the effectiveness and safety of the Proxifuse Hammer Toe Device when utilized for bone fixation. Approximately 4 US sites will participate. The primary endpoint will evaluate the 6 month post surgery change from baseline in the PROMIS Pain Interference computerized adaptive test (CAT) score.

Conditions

  • Toe Joint Deformity

Sponsors & Collaborators

  • Cartiva, Inc.

    lead INDUSTRY

Principal Investigators

  • Katie Strother · Cartiva, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452671 on ClinicalTrials.gov